Top Markets
Coin of the day
Malin Corporation plc Malin Corporation plc

Malin Corporation plc

MLC
Classifica tra le azioni #20971
Malin Corporation plc, through its subsidiaries, operates in the life sciences... Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Prezzo delle azioni
$9.13
Capitalizzazione di mercato
$39.27K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-11.76%
Paese
IE
Scambia Malin Corporation plc (MLC)

Categoria

EPS per Malin Corporation plc (MLC)
EPS al December 2025 TTM: $-0.80
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Malin Corporation plc, l’EPS attuale della società (TTM) è $-0.80. Alla fine del 2023, la società aveva un EPS di 0.00 un aumento rispetto a rispetto a quello del 2022, che era di $0.41.
Storico EPS per Malin Corporation plc da 2015 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-0.80 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 $0.41 450.07%
2021 $0.07 -96.81%
2020 $2.33 -1,985.01%
2019 $-0.12 -89.37%
2018 $-1.16 -59.02%
2017 $-2.83 26.95%
2016 $-2.23 26.03%
2015 $-1.77 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$1.57 -297.07%
FR
$7.03 -980.91%
DE
$0.23 -129.34%
JP
$6.03 -855.83%
US
$0.51 -163.44%
IN